Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions
Top Cited Papers
- 1 October 2003
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 92 (8), 930-935
- https://doi.org/10.1016/s0002-9149(03)00972-x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Stroke Complicating Percutaneous Coronary InterventionsCirculation, 2002
- Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial InfarctionNew England Journal of Medicine, 2002
- Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: Results in 7,472 octogenariansJournal of the American College of Cardiology, 2000
- A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical CareNew England Journal of Medicine, 1999
- Abciximab Therapy and Unplanned Coronary Stent DeploymentCirculation, 1998
- Effect of anaemia and cardiovascular disease on surgical mortality and morbidityThe Lancet, 1996
- Bleeding Complications With the Chimeric Antibody to Platelet Glycoprotein IIb/IIIa Integrin in Patients Undergoing Percutaneous Coronary InterventionCirculation, 1995
- Vascular complications after balloon and new device angioplasty.Circulation, 1993
- Retrospective Comparison of Outcome of 100 Consecutive Open Cholecystectomies and 100 Consecutive Laparoscopic CholecystectomiesSouthern Medical Journal, 1993
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988